Natural Covid antibodies last 7 months in children: Study

For the study, published in the journal 'Pediatrics', the team examined data from 218 children across the state of Texas between the age of 5 and 19

coronavirus
Photo by Viktor Forgacs on Unsplash
IANS New York
2 min read Last Updated : Mar 19 2022 | 5:27 PM IST

Children previously infected with Covid-19 develop natural circulating antibodies that last for at least seven months, finds a new study.

The study showed that while 96 per cent of those infected with Covid-19 continued to have antibodies up to seven months later, well over half (58 per cent) of the samples were negative for infection-induced antibodies at their third and final measurement.

"These findings are important because the information we collected from children infected with Covid-19 didn't differ at all by whether a child was asymptomatic, the severity of symptoms, when they had the virus, were at a healthy weight or had obesity, or by gender. It was the same for everyone," said researcher Sarah Messiah from The University of Texas Health at Houston.

For the study, published in the journal 'Pediatrics', the team examined data from 218 children across the state of Texas between the age of 5 and 19 who were enrolled in the Texas CARES survey that began in October 2020 to assess Covid-19 antibody status over time among a population of adults and children in Texas.

The volunteers who enrolled for the study provided researchers with three separate blood draws. Samples were collected before the vaccine rollout and during the Delta and Omicron variants. To date, investigators have completed three different phases of the study.

The researcher said that the results are just a step in understanding the virus' impact on children.

To date, 14 million kids in the US have tested positive for the virus, she said.

--IANS

vc/arm

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus VaccineCoronavirus Tests

First Published: Mar 19 2022 | 5:27 PM IST

Next Story